Senate panel endorses healthcare overhaul

A key U.S. Senate committee endorsed a sweeping healthcare overhaul on Tuesday, gaining the support of an influential Republican and delivering President Barack Obama a victory on his top domestic priority. Read Full Article here.

Corporate tax hikes likely delayed

President Barack Obama remains committed to ending unfair loopholes and tax breaks for international corporations, but congressional tax writers and others doubt that will happen without broader reforms, such as cutting the top corporate tax rate. Read Full Article here.

Cisco to buy wireless gear maker Starent for $2.9 billion

Cisco Systems Inc plans to buy advanced wireless equipment maker Starent Networks Corp for $2.9 billion to boost its product offerings as phone carriers build out next-generation networks. Read Full Article here.

P&G tells investors it is primed for growth

Procter & Gamble Co will introduce more value-priced items, increase its focus on emerging markets and take other steps to ensure growth after a difficult year, its top executives said on Tuesday. Read Full Article here.

J&J quarterly sales miss estimates, shares fall

Johnson & Johnson posted weaker-than-expected quarterly revenue on Tuesday as sales of prescription drugs and heart stents disappointed, sending its shares down 2.5 percent. Read Full Article here.

Supreme Court to hear appeal by Enron's Skilling

The U.S. Supreme Court said on Tuesday that it would hear an appeal by former Enron Corp Chief Executive Jeffrey Skilling of his 2006 felony conviction stemming from the giant energy trader's collapse. Read Full Article here.

BofA, Chase executives say US housing still fragile

Executives from two of the United States' biggest home mortgage lenders said the nation's housing market is still in a tenuous state despite signs of stability over the summer months. Read Full Article here.

Study charts links between mobile phones, tumors

Studies on whether mobile phones can cause cancer, especially brain tumors, vary widely in quality and there may be some bias in those showing the least risk, researchers reported on Tuesday. Read Full Article here.